Foxy Fill is a cross-linked monophasic hyaluronic acid gel at 20 mg/ml, sold by HJ Corporation in a large 60 ml vial and positioned for body volumizing such as breast, buttock, and body contouring. It is a colorless transparent gel with a 36-month shelf life. This is a serious medical decision, not a DIY shortcut.

What is Foxy Fill, and what is it positioned for?

Foxy Fill is a hyaluronic acid (HA) filler. HA is a sugar molecule your body already makes, and in fillers it is cross-linked so it holds its shape and resists breaking down. Foxy Fill is monophasic, meaning the gel is a single smooth phase rather than a mix of particle sizes. The manufacturer lists it at 20 mg/ml in a 60 ml vial with a 36-month shelf life.

What sets it apart from most fillers is scale. A typical facial syringe holds about 1 ml. Foxy Fill’s 60 ml format signals what the manufacturer positions it for: large-volume body work, including breast and buttock augmentation and broader contouring. That positioning is exactly where independent caution is loudest, so it deserves a careful, honest read.

Log Notes. This page explains what Foxy Fill is and how its maker positions it. It gives no doses, depths, injection sites, mixing steps, or technique. Those belong to a licensed professional and the official guide, not a blog. Nothing here is medical advice, and large-volume body filling is never a do-it-yourself procedure.

Why do regulators warn against large-volume body fillers?

Because the risks are real and well documented. The U.S. Food and Drug Administration explicitly warns against using dermal fillers for body contouring or enhancement of large areas such as the breasts, buttocks, or spaces between muscles, citing serious injuries including infection, lumps, scarring, and the risk of filler entering a blood vessel (FDA, dermal fillers). No HA body filler is FDA-approved for those uses.

That caution is the heart of this post. A product can be sold somewhere and still sit outside what regulators consider appropriate use. Large-volume injection into the body is not a bigger version of a lip touch-up. It is a different risk category, and the FDA’s guidance is direct about that gap. Treat the manufacturer’s positioning as marketing, and treat the regulatory caution as the part that protects you.

For contrast, facial HA fillers are designed for small, targeted volumes in defined areas. If your interest is the face rather than the body, our notes on a deeper facial gel like CaratFill Sub-Q and a lip-focused product like Lipfle show how different the scale and use case really are.

What would a careful record look like?

A complete one, because high-volume body procedures carry follow-up that matters. If you ever pursue any aesthetic treatment with a licensed professional, the value of a private record is the same regardless of product: it captures what was done, when, and how things changed, so you and your provider are working from facts instead of memory.

That is the role Dosefi plays. You log each session with its date and a photo, set a reminder for any review window your provider gives you, and self-rate how things look and feel over time so a real timeline replaces guesswork. A log never makes a procedure safe; it just keeps your own history honest and organized.

If you are weighing body versus facial options, reading widely helps. Our overviews of CaratFill Sub-Q and lip work like Lipfle make the volume difference plain, and any decision about Foxy Fill itself belongs with a qualified professional who can assess you in person.

A grounded takeaway

Foxy Fill is a 20 mg/ml monophasic HA gel sold in a large 60 ml format and positioned for body volumizing. The honest headline is the regulatory one: the FDA warns against using dermal fillers for large-volume body contouring, citing serious documented risks. This is a medical decision for a licensed professional, never a DIY route. The official product guide is attached for your records only.

Sources